Fazong Wu

1.5k total citations
38 papers, 1.0k citations indexed

About

Fazong Wu is a scholar working on Hepatology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fazong Wu has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fazong Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (5 papers). Fazong Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (5 papers). Fazong Wu collaborates with scholars based in China and Japan. Fazong Wu's co-authors include Jianfei Tu, Zhongwei Zhao, Jiansong Ji, Jiansong Ji, Liyun Zheng, Jingjing Song, Qiaoyou Weng, Minjiang Chen, Dengke Zhang and Shiji Fang and has published in prestigious journals such as ACS Nano, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Fazong Wu

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fazong Wu China 17 507 333 256 241 207 38 1.0k
Zhifei Lin China 14 660 1.3× 405 1.2× 220 0.9× 313 1.3× 159 0.8× 22 1.3k
Vincent Wai‐Hin Yuen Hong Kong 17 536 1.1× 375 1.1× 222 0.9× 311 1.3× 94 0.5× 20 1.0k
Rong Su China 15 420 0.8× 238 0.7× 179 0.7× 256 1.1× 97 0.5× 44 951
Yanjing Zhu China 12 862 1.7× 589 1.8× 151 0.6× 340 1.4× 236 1.1× 18 1.4k
Qingguang Liu China 21 855 1.7× 531 1.6× 125 0.5× 213 0.9× 117 0.6× 55 1.2k
Robin Kit‐Ho Lai Hong Kong 11 639 1.3× 505 1.5× 177 0.7× 321 1.3× 82 0.4× 14 1.2k
Le‐Qun Li China 20 685 1.4× 598 1.8× 197 0.8× 542 2.2× 312 1.5× 63 1.5k
Dinghua Yang China 16 485 1.0× 387 1.2× 191 0.7× 398 1.7× 77 0.4× 41 1000
Jian Kong China 19 433 0.9× 345 1.0× 100 0.4× 175 0.7× 324 1.6× 37 1.0k

Countries citing papers authored by Fazong Wu

Since Specialization
Citations

This map shows the geographic impact of Fazong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fazong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fazong Wu more than expected).

Fields of papers citing papers by Fazong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fazong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fazong Wu. The network helps show where Fazong Wu may publish in the future.

Co-authorship network of co-authors of Fazong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fazong Wu. A scholar is included among the top collaborators of Fazong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fazong Wu. Fazong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Tingting, Fazong Wu, Zhongwei Zhao, et al.. (2025). Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review. Journal of Nanobiotechnology. 23(1). 166–166. 9 indexed citations
2.
3.
Chen, Xiaoxiao, Muhammad Sohail, Fazong Wu, et al.. (2024). Self-targeted smart polyester nanoparticles for simultaneous Delivery of photothermal and chemotherapeutic agents for efficient treatment of HCC. Biomaterials Science. 12(24). 6368–6381.
4.
Zheng, Liyun, Shiji Fang, Jiale Chen, et al.. (2024). Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver Cancer. ACS Nano. 18(40). 27597–27616. 19 indexed citations
5.
Chen, Minjiang, Lin Shen, Jiayi Ding, et al.. (2023). Monodisperse CaCO3-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatment. International Journal of Biological Macromolecules. 231. 123160–123160. 15 indexed citations
6.
Tu, Jianfei, Fazong Wu, Li Chen, et al.. (2021). Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway. Frontiers in Oncology. 10. 680500–680500. 34 indexed citations
7.
Chen, Minjiang, Xiaoling Xu, Gaofeng Shu, et al.. (2021). Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy. ACS Applied Bio Materials. 4(4). 3476–3489. 11 indexed citations
8.
Fang, Shiji, Jinyu Zhu, Liyun Zheng, et al.. (2021). A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation. Frontiers in Molecular Biosciences. 8. 662366–662366. 11 indexed citations
9.
Fan, Xiaoxi, Zhongwei Zhao, Jingjing Song, et al.. (2021). LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A. Cancer Cell International. 21(1). 150–150. 9 indexed citations
10.
Lv, Xiuling, Minjiang Chen, Chunli Kong, et al.. (2021). Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation. European Journal of Radiology. 144. 109955–109955. 15 indexed citations
11.
12.
Zhao, Zhongwei, Jingjing Song, Dengke Zhang, et al.. (2020). Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib. Life Sciences. 264. 118642–118642. 32 indexed citations
13.
Tang, Bufu, Jinyu Zhu, Jie Li, et al.. (2020). The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Communication and Signaling. 18(1). 174–174. 170 indexed citations
14.
Tang, Bufu, Jinyu Zhu, Baohui Zhang, et al.. (2020). Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis. Frontiers in Immunology. 11. 592084–592084. 56 indexed citations
15.
16.
Fan, Xiaoxi, Jingjing Song, Zhongwei Zhao, et al.. (2019). Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT. Cancer Letters. 460. 119–127. 17 indexed citations
17.
Zhao, Zhongwei, Jingjing Song, Xiaoxi Fan, et al.. (2019). Primary Clinical Application of Y-Shaped Jogged Stent Implantation in Patients with Malignant Hilar Biliary Obstruction. Journal of Gastrointestinal Surgery. 23(4). 745–750. 1 indexed citations
18.
Xu, Min, Shiji Fang, Jingjing Song, et al.. (2018). CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance. Cell Death and Disease. 9(10). 957–957. 35 indexed citations
19.
Song, Jingjing, Xiaoxi Fan, Zhongwei Zhao, et al.. (2017). <sup>125</sup>I&nbsp;brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy：a comparison with best supportive care. OncoTargets and Therapy. Volume 10. 1345–1352. 15 indexed citations
20.
Tu, Jianfei, Yahui Ding, Xihui Ying, et al.. (2016). Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival. Scientific Reports. 6(1). 35056–35056. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhifei Lin Breakdown of academic impact, for papers by Vincent Wai‐Hin Yuen Breakdown of academic impact, for papers by Rong Su Breakdown of academic impact, for papers by Yanjing Zhu Breakdown of academic impact, for papers by Qingguang Liu Breakdown of academic impact, for papers by Robin Kit‐Ho Lai Breakdown of academic impact, for papers by Le‐Qun Li Breakdown of academic impact, for papers by Dinghua Yang Breakdown of academic impact, for papers by Jian Kong
Rankless by CCL
2026